Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: Oncogenic and immunomodulations involving the action of tumor necrosis factor

Environmental Health Perspectives

Volumn 116, Issue 6, 2008, Pages 769-776

  Bakshi, Shlomo ^a,b   Zhang, Xiang ^a   Godoy Tundidor, Sonia ^a,c   Cheng, Robert Yuk Sing ^a,d   Sartor, Maureen A ^a   Medvedovic, Mario ^a   Ho, Shuk Mei ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Innovative R and D Abic Teva Pharmaceutical ^*  (Israel)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carcinogenesis; Cytokine; Global expression profiling; Heavy metals; Immune response; Inflammation; Ingenuity Pathway Analysis; Knowledge based anlaysis; Prostate cancer

Indexed keywords

ADAM PROTEIN; ADAM8 PROTEIN; CADMIUM CHLORIDE; CELL PROTEIN; CYCLOOXYGENASE 2; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 24; INTERLEUKIN 8; NEUTRALIZING ANTIBODY; PROTEIN EDN1; SERPIN B2; TUMOR NECROSIS FACTOR;

ARTICLE; CELL CYCLE REGULATION; CELL GROWTH; CELL IMMORTALIZATION; CELL SYNCHRONIZATION; CELL VIABILITY; CHEMICAL CARCINOGENESIS; COMPUTER PROGRAM; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

ANTIBODIES; CADMIUM; CELL CYCLE; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 46749156741     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11215     Document Type: Article

References (59)

1. Achanzar WE, Achanzar KB, Lewis JG, Webber MM, Waalkes MP. 2000. Cadmium induces c-myc, p53, and c-jun expression in normal human prostate epithelial cells as a prelude to apoptosis. Toxicol Appl Pharmacol 164:291-300.
2. Achanzar WE, Diwan BA, Liu J, Quader ST, Webber MM, Waalkes MP. 2001. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res 61:455-458.
3. Babbar N, Casero RA Jr. 2006. Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res 66:11125-11130.
4. Baecklund M, Pedersen NL, Bjorkman L, Vahter M. 1999. Variation in blood concentrations of cadmium and lead in the elderly. Environ Res 80:222-230.
5. Banno T, Gazel A, Blumenberg M. 2004. Effects of tumor necrosis factor-α (TNFα) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 279:32633-32642.
6. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, et al. 2006. NCBI GEO: mining tens of millions of expression profiles - database and tools update. Nucleic Acids Res 35:D760-D765.
7. Bioconductor. 2008. affyQCReport. Available: http://www.bioconductor.org/packages/release/Software.html [accessed 3 May 2008].
8. Brys M, Nawrocka AD, Miekos E, Zydek C, Foksinski M, Barecki A, et al. 1997. Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res 59:145-152.
9. Chen CC, Sun YT, Chen JJ, Chiu KT. 2000. TNF-α-induced cyclooxygenase-2 expression in human lung epithelial cells: Involvement of the phospholipase C-γ2, protein kinase C-α, tyrosine kinase, NF-κB-inducing kinase, and I-κB kinase 1/2 pathway. J Immunol 165:2719-2728.
10. David MD, Bertoglio J, Pierre J. 2003. Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression. Oncogene 22:3386-3394.
11. Fritzsche FR, Jung M, Xu C, Rabien A, Schicktanz H, Stephan C, et al. 2006. ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis. Virchows Arch 449:628-636.
12. Godara G, Pecher S, Jukic DM, D'Antonio JM, Akhavan A, Nelson JB, et al. 2007. Distinct patterns of endothelin axis expression in primary prostate cancer. Urology 70:209-215.
13. Govil PK, Sorlie JE, Murthy NN, Sujatha D, Reddy GL, Rudolph-Lund K, et al. 2007. Soil contamination of heavy metals in the Katedan Industrial Development Area, Hyderabad, India. Environ Monit Assess 140:313-323.
14. Goyer RA, Liu J, Waalkes MP. 2004. Cadmium and cancer of prostate and testis. Biometals 17:555-558.
15. Granchi S, Brocchi S, Bonaccorsi L, Baldi E, Vinci MC, Forti G, et al. 2001. Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens. Prostate 49:267-277.
16. Handsley MM, Edwards DR. 2005. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 115:849-860.
17. Hussain T, Gupta S, Mukhtar H. 2003. Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett 191:125-135.
18. IARC (International Agency for Research on Cancer). 1993. Cadmium and cadmium compounds. IARC Monogr Eval Carcinog Risk Hum 58:119-238.
19. Ikawa H, Kameda H, Kamitani H, Baek SJ, Nixon JB, Hsi LC, et al. 2001. Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells. Exp Cell Res 267:73-80.
20. Ingenuity Systems. 2008. Ingenuity Pathways Analysis. Available: http://www.ingenuity.com/products/pathways_analysis.html [accessed 3 May 2008].
21. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, 2007. CA Cancer J Clin 57:43-66.
22. Kawakami K. 2005. Cancer gene therapy utilizing interleukin-13 receptor alpha2 chain. Curr Gene Ther 5:213-223.
23. Kawakami K, Husain SR, Bright RK, Puri RK. 2001. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts. Cancer Gene Ther 8:861-868.
24. Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK. 2006. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy. Cancer 107:1407-1418.
25. Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, et al. 2004. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK. Oncogene 23:2197-2205.
26. Lindegaard PM, Hansen SO, Christensen JE, Andersen BB, Andersen O 1990. The distribution of cadmium within the human prostate. Biol Trace Elem Res 25:97-104.
27. Lora JM, Zhang DM, Liao SM, Burwell T, King AM, et al. 2005. Tumor necrosis factor-α triggers mucus production in airway epithelium through an IκB kinase β-dependent mechanism. J Biol Chem 280:36510-36517.
28. Mobley JA, Leav I, Zielie P, Wotkowitz C, Evans J, Lam YW, et al. 2003. Branched fatty acids in dairy and beef products markedly enhance α-mathylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol Biomarkers Prev 12:775-783.
29. Murphy C, McGurk M, Pettigrew J, Santinelli A, Mazzucchelli R, Johnston PG, et al. 2005. Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer. Clin Cancer Res 11:4117-4127.
30. Nakamura K, Yasunaga Y, Ko D, Xu LL, Moul JW, Peehl DM, et al. 2002. Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int J Oncol 20:543-547.
31. National Center for Biotechnology Information. 2008a. Entrez Gene. Available: http://www.ncbi.nlm.nih.gov/sites/entrez [accessed 30 April 2008].
32. National Center for Biotechnology Information. 2008b. Gene Expression Omnibus. Available: http://www.ncbi.nlm.nih.gov/projects/geo/ [accessed 30 April 2008].
33. NTP. 2004. Cadmium and cadmium compounds. In: 11th Report on Carcinogens. Research Triangle Park, NC:National Toxicology Program, III-42-III-44. Available: http://ntp.niehs.nih.gov/ntp/roc/eleventh/ profiles/s028cadm.pdf [accessed 1 May 2008].
34. Qu W, Ke H, Pi J, Broderick D, French JE, Webber MM, et al. 2007. Acquisition of apoptotic resistance in cadmium-transformed human prostate epithelial cells: Bcl-2 overexpression blocks the activation of JNK signal transduction pathway. Environ Health Perspect 115:1094-1100.
35. R Foundation for Statistical Computing. 2008. The R Project for Statistical Computing. Available: http://www.r-project.org/ [accessed 30 April 2008].
36. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. 1993. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 268:5834-5839.
37. Sarkar D, Lebedeva IV, Su ZZ, Park ES, Chatman L, Vozhilla N, et al. 2007. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus. Cancer Res 67:5434-5442.
38. Sartor MA, Tomlinson CR, Wesselkamper SC, Sivaganesan S, Leikauf GD, Medvedovic M. 2006. Intensity-based hierarchical Bayes method improves testing for differentially expressed genes in microarray experiments. BMC Bioinformatics 7:538.
39. Satarug S, Moore MR. 2004. Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect 112:1099-1103.
40. Schlomann U, Rathke-Hartlieb S, Yamamoto S, Jockusch H, Bartsch JW. 2000. Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. J Neurosci 20:7964-7971.
41. Sciarra A, Mariotti G, Salciccia S, Gomez AA, Monti S, Toscano V, et al. 2007. Prostate growth and inflammation. J Steroid Biochem Mol Biol 108:254-260.
42. Shealy DJ, Visvanathan S. 2008. Anti-TNF antibodies: lessons from the past, roadmap for the future. Handb Exp Pharmacol 181:101-129.
43. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3. Available: http://www.statsci.org/smyth/pubs/ebayes.pdf [accessed 30 April 2008].
44. Subbarayan V, Sabichi AL, Llansa N, Lippman SM, Mentor DG. 2001. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-α in normal and malignant prostate cells. Cancer Res 61:2720-2726.
45. Sun LN, Zhang YH, Sun TH, Gong ZQ, Lin X, Li HB. 2006. Temporal-spatial distribution and variability of cadmium contamination in soils in Shenyang Zhangshi irrigation area, China. J Environ Sci (China) 18:1241-1246.
46. Syed V, Zhang X, Lau KM, Chang R, Mukherjee K, Ho SM. 2005. Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells. Oncogene 24:1-16.
47. Tam NN, Leav I, Ho SM. 2007. Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. Am J Pathol 171:1334-1341.
48. Tam NN, Szeto CY, Sartor MA, Medvedovic M, Ho SM. 2008. Gene-expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17β-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats. Neoplasia 10:20-40.
49. Treede I, Braun A, Sparla R, Kuhnel M, Giese T, Turner JR, et al. 2007. Anti-inflammatory effects of phosphatidyl-choline. J Biol Chem 282:27155-27164.
50. UCSC Genome Bioinformatics. 2008. BLAT Search Genome. Available: http://genome.ucsc.edu/cgi-bin/hgBlat [accessed 3 May 2008].
51. Vinceti M, Venturelli M, Sighinolfi C, Trerotoli P, Bonvicini F, Ferrari A, et al. 2007. Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ 373:77-81.
52. Waalkes MP. 2000. Cadmium carcinogenesis in review. J Inorg Biochem 79:241-244.
53. Waalkes MP. 2003. Cadmium carcinogenesis. Mutat Res 533:107-120.
54. Waalkes MP, Rehm S, Riggs CW, Bare RM, Devor DE, Poirier LA, et al. 1989. Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site. Cancer Res 49:4282-4288.
55. Wang Y, Jensen PJ, 1998. Regulation of the level and glycosylation state of plasminogen activator inhibitor type 2 during human keratinocyte differentiation. Differentiation 63:93-99.
56. Wetherill YB, Petre CE, Monk KR, Puga A, Knudsen KE. 2002. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells. Mol Cancer Ther 1:515-524.
57. Woods M, Wood EG, Bardswell SC, Bishop-Bailey D, Barker S, Wort SJ, et al. 2003. Role for nuclear factor-κB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Mol Pharmacol 64:923-931.
58. Yan S, Ling QC, Bao ZY. 2007. Metals contamination in soils and vegetables in metal smelter contaminated sites in Huangshi, China. Bull Environ Contain Toxicol 79:361-366.
59. Zhang X, Leung YK, Ho SM. 2007. AP-2 regulates the transcription of estrogen receptor (ER)-β by acting through a methylation hotspot of the ON promoter in prostate cancer cells. Oncogene 26:7346-7354.